University of Chicago Medicine Cardiac Amyloidosis Program | oneAMYLOIDOSISvoice
Academic & Health Care Centers

University of Chicago Medicine Cardiac Amyloidosis Program

5841 S. Maryland Avenue
Chicago, Illinois, United States
Phone   Web  

The University of Chicago Medicine is one of only a few institutions in the country that specialize in cardiac amyloidosis. Their Cardiac Amyloidosis Program includes a team of multidisciplinary experts who have the experience to diagnose and treat this complex condition.

University of Chicago Medicine is committed to offering patients the best quality of life during and after treatment and they are doing groundbreaking research into the disease and its causes, so that they can identify high-risk patients and develop effective, long-term treatments. They also offer genetic testing for patients and their families.

While several types of amyloidosis affect the heart, their cardiologists primarily treat the following two types of Amyloidosis:

• AL amyloidosis (also called primary amyloidosis.

• TTR amyloidosis 

The team includes healthcare professionals in the following areas:

Amit R. Patel, MD; Nitasha Sarswat, MD


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.